Loading...

Bromodeoxyuridine (BrdU)

Pricing & Availability
Regulatory Status
RUO
Other Names
5-Bromo-2'-Deoxyuridine, BUDR , 5-BrdU, 5-Bromouracil deoxyriboside, 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil
Ave. Rating
Submit a Review
Product Citations
publications
BrdU_Chemical_FC_Human_030714
Human T lymphoblastic leukemia cell line, HUT-78, was pulsed with BrdU for 1 hour, and then stained with anti-BrdU (clone Bu20a) APC by following BrdU staining procedures. 7-AAD was added before the sample acquisition.
  • BrdU_Chemical_FC_Human_030714
    Human T lymphoblastic leukemia cell line, HUT-78, was pulsed with BrdU for 1 hour, and then stained with anti-BrdU (clone Bu20a) APC by following BrdU staining procedures. 7-AAD was added before the sample acquisition.
  • BrdU_Chemical_FC_Mouse_030714
    BALB/c mouse was injected with BrdU. Two hours later, the bone marrow cells were harvested and then stained with anti-BrdU (clone Bu20a) APC by following BrdU staining procedures. 7-AAD was added before the sample acquisition.
Cat # Size Price Quantity Check Availability Save
423401 25 mg 62€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Bromodeoxyuridine, also known as BrdU (MW=307.1 Da), is a synthetic analog of thymidine that is incorporated into DNA during S-phase of the cell cycle. BrdU is rapidly assimilated by proliferating cells and can be detected with anti-BrdU specific antibodies by different techniques like flow cytometry, immunofluorescence, and immunohistochemistry. BrdU is widely used to measure DNA synthesis, study the cell cycle, and identify proliferating cells. In addition, it has been used as an antiviral and antineoplastic drug.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
This product consists of 5 vials. Each vial contains 5 mg/500 µl of BrdU in an aqueous solution.
Preparation
This BrdU solution has been filtrated through a 0.22 µm membrane and contains no preservatives.
Concentration
10 mg/ml
Storage & Handling
Store at -70°C upon receipt. Once thawed, the solution is stable between 2°C and 8°C for 4 weeks. Avoid repeated freeze/thaw cycles. Protect from light. Handle in aseptic conditions.
Application

ICFC - Quality tested
Recommended Usage

Recommended usage includes in vivo and in vitro measurement of DNA synthesis, study of the cell cycle, and labeling of proliferating cells.

Application Notes

This product can be used for in vivo and in vitro labeling of proliferating cells as described in the following protocols:

a) Administration in drinking water: Dilute the BrdU in drinking water to a concentration of 0.8-1.0 mg/ml. Give to animals for consumption ad libitum for up to 4 weeks.
Note: This solution should be protected from light and should be refreshed at least every 3 days. BrdU can be toxic, even lethal. If animals are going to be fed with BrdU for more than 2 weeks, then closely monitor the animals for signs of toxicity.

b) Administration by injection: Dilute the BrdU in sterile saline solution or PBS for a dose of 50-100 mg BrdU/kg, inject the animal intraperitoneally (i.p.) or intravenously (i.v.). In actively proliferating cells, BrdU-labeled DNA can be detected within one hour of the injection.

c) In vitro administration of BrdU: Dilute the BrdU 1:30 (0.33 mg/ml) with sterile media and pulse the cells by adding 10 µl of this solution to each ml of cultured cells, BrdU final concentration is 10 µM (3.3 µg/ml). A cell density =2x106 cells/ml is commonly used; incubate the cells for desired time.
Note: Special care should be taken to not disturb the cells before pulsing them with BrdU and during the incubation time (e.g. avoid changes in temperature and do not centrifuge the cells), as it may interfere with the cell cycle.

The protocols above outline three recommended uses for this product. Final conditions will depend on the purpose of the experiment and characteristics of the target cells.

Product Citations
  1. Woo MS, et al. 2021. J Exp Med. :218. PubMed

Antigen Details

Structure
Nucleoside derived from uridine, 307.1 Da, molecular formula C9H11BrN2O5
Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Cell Cycle/DNA Replication, DNA Repair/Replication, Signal Transduction
Antigen References

1. Barker JM, et al. 2013. PLoS One 8:e63692.
2. Duque A and Rakic P. 2011. J. Neurosci. 31:15205.
3. Robbins S, et al. 2011. J. Vis. Exp. 55:2855.
4. Broekhuizen CA, et al. 2010. Infect. Immun. 78:954.
5. van der Wath RC, et al. 2009. PLoS One 4:e6972.

Gene ID
NA
Go To Top Version: 2    Revision Date: 05-11-2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account